deCODE biostructures Initiates Research Collaboration with Genus Onocology
News Jun 22, 2007
deCODE biostructures, Inc. has announced the signing of a collaborative research agreement with Genus Oncology, LLC.
Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology. The research and milestone-based collaboration provides Genus Oncology with access to deCODE’s expertise in de novo protein crystal structure determination, from the engineering of synthetic genes to the determination of high resolution crystal structures.
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA (exRNA) in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.READ MORE
Is there a link between differences in IQ test performance and the activity of certain genes? Researchers have shown that modifications in the structure of a specific gene have a negative impact on individual test performance. This suggests that environmentally-induced epigenetic changes to our genetic material have a greater impact on intelligence than previously thought.